Betty Tello
Primary Care · Saint Cloud, FLNPI 1033892823
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 213 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 17.9% — the pattern of someone who eats at a lot of different presentations. Among primary care clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 213 payments — averaging $24.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$941
- Otsuka America Pharmaceutical, Inc.$596
- Lundbeck LLC$473
- Pfizer$471
- Axsome Therapeutics, Inc.$324
- Teva Pharmaceuticals USA, Inc.$274
- plus $2K from 23 others
What the payments were for
- Food & beverage$5,264100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 40 | $941 |
| Otsuka America Pharmaceutical, Inc. | 22 | $596 |
| Lundbeck LLC | 35 | $473 |
| Pfizer | 29 | $471 |
| Axsome Therapeutics, Inc. | 10 | $324 |
| Teva Pharmaceuticals USA, Inc. | 10 | $274 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 6 | $222 |
| Neurocrine Biosciences, Inc. | 5 | $217 |
| EMD Serono, Inc. | 5 | $197 |
| Amneal Pharmaceuticals LLC | 4 | $186 |
| Microtransponder, Inc. | 1 | $167 |
| UCB, Inc. | 5 | $164 |
| Johnson & Johnson | 3 | $154 |
| Corium, LLC | 8 | $128 |
| SK Life Science, Inc. | 3 | $99 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $81 |
| Acadia Pharmaceuticals Inc | 3 | $72 |
| Merz Pharmaceuticals, LLC | 3 | $67 |
| Supernus Pharmaceuticals, Inc. | 2 | $58 |
| Alkermes, Inc. | 2 | $54 |
| Scilex Pharmaceuticals Inc. | 3 | $54 |
| Eisai Inc. | 2 | $50 |
| Vanda Pharmaceuticals Inc. | 2 | $46 |
| Lilly USA, LLC | 2 | $41 |
| AstraZeneca | 1 | $34 |
| E.r. Squibb & Sons, L.L.C. | 1 | $31 |
| Hyperfine Operations, Inc. | 1 | $26 |
| Impel Pharmaceuticals LLC | 1 | $20 |
| Idorsia Pharmaceuticals US Inc | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,264 in reported general payments places this provider in the 95th percentile of 725 primary care providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Quetiapine Fumarate | 11 | $144 |
| Aripiprazole | 13 | $101 |
| Trazodone Hcl | 15 | $89 |
Paid to pharmacies, not to this prescriber.
Other primary care in Saint Cloud
- Yolanda PalmeroSaint Cloud$11K
- Paul ChanOrlando$447K
- Jenny WestPensacola$80K
- Railet RodriguezAltamonte Springs$14K
- Kevin HanawayFort Lauderdale$12K
- Kelly ChewningAlachua$11K
- Erica ClarkCitrus Springs$11K
- Michelle SelvaggiLakewood Ranch$10K
- Kristen DeasonTallahassee$10K
- Robert PerriPalm Coast$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.